13 January 2022: Information for Healthcare Professionals - Casirivimab/Imdevimab (Ronapreve) 120 mg/ml Solution for Injection/Infusion: Considerably reduced neutralisation of the Omicron variant fulllength spike protein from the casirivimab/imdevimab antibody combination

date of issue 13.01.2022

file

• file "13 January 2022: Information for Healthcare Professionals - Casirivimab/Imdevimab (Ronapreve) 120 mg/ml Solution for Injection/Infusion: Considerably reduced neutralisation of the Omicron variant fulllength spike protein from the casirivimab/imdevimab antibody combination"download(PDF, 499KB, File does not meet accessibility standards.)